In vitro and in vivo evaluation of didymin cyclodextrin inclusion complexes: characterization and chemosensitization activity

Didymin is a dietary flavonoid that first found in citrus fruits, and possesses antioxidant properties. Our preliminary experiments first discovered that didymin was able to sensitize the resistant cancer cells against chemotherapeutics and combat multidrug resistance. However, its poor aqueous solu...

Full description

Saved in:
Bibliographic Details
Published inDrug delivery Vol. 27; no. 1; pp. 54 - 65
Main Authors Yao, Qing, Lin, Meng-Ting, Lan, Qing-Hua, Huang, Zhi-Wei, Zheng, Ya-Wen, Jiang, Xue, Zhu, Yin-Di, Kou, Longfa, Xu, He-Lin, Zhao, Ying-Zheng
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.01.2020
Taylor & Francis Ltd
Taylor & Francis Group
Subjects
Online AccessGet full text
ISSN1071-7544
1521-0464
1521-0464
DOI10.1080/10717544.2019.1704941

Cover

More Information
Summary:Didymin is a dietary flavonoid that first found in citrus fruits, and possesses antioxidant properties. Our preliminary experiments first discovered that didymin was able to sensitize the resistant cancer cells against chemotherapeutics and combat multidrug resistance. However, its poor aqueous solubility and resultant low bioavailability limit its potentials as an adjuvant phytochemical drug for chemotherapy. Thus, this study prepared the inclusion complex of didymin with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin to improve its bioavailability and then evaluate their chemosensitization effects. The didymin inclusion complexes formulation was prepared and their host-guest structure was characterized by FT-IR, PXRD, DSC, and SEM techniques. In vitro/in vivo results demonstrated that didymin inclusion complex enhanced its water solubility and orally bioavailability. Furthermore, didymin inclusion complex exerted considerable chemosensitivity potency, and improve the anti-tumor effects of chemotherapeutics in vivo. Therefore, didymin inclusion complex could provide a safe, effective, economical, and adjuvant drug for future treatment of chemoresistant cancers.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
Supplemental data for this article can be accessed here.
ISSN:1071-7544
1521-0464
1521-0464
DOI:10.1080/10717544.2019.1704941